RIL
Rothschild Investment LLC Portfolio holdings
AUM
$1.6B
1-Year Return
17.99%
This Quarter Return
-0.9%
1 Year Return
+17.99%
3 Year Return
+73.94%
5 Year Return
+135.61%
10 Year Return
+254.21%
AUM
$1.49B
AUM Growth
-$32.5M
(-2.1%)
Cap. Flow
+$6.63M
Cap. Flow
% of AUM
0.44%
Top 10 Holdings %
Top 10 Hldgs %
22.44%
Holding
3,131
New
179
Increased
1,559
Reduced
660
Closed
105
Top Buys
| 1 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$8.86M |
| 2 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$6.7M |
| 3 |
GE Aerospace
GE
|
+$5.91M |
| 4 |
Caterpillar
CAT
|
+$5.55M |
| 5 |
TopBuild
BLD
|
+$3.47M |
Top Sells
| 1 |
Truist Financial
TFC
|
+$9.87M |
| 2 |
Invitation Homes
INVH
|
+$6.29M |
| 3 |
Global Payments
GPN
|
+$5.73M |
| 4 |
Stanley Black & Decker
SWK
|
+$3.49M |
| 5 |
Apple
AAPL
|
+$2.52M |
Sector Composition
| 1 | Technology | 16.17% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 9.57% |
| 4 | Industrials | 8.64% |
| 5 | Communication Services | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
ODP
ODP
$611M
| $931 | ﹤0.01% |
65
+40
| +160% | +$573 |
|
2352
Spectrum Brands
SPB
$1.3B
| $930 | ﹤0.01% |
13
-115
| -90% | -$8.23K |
|
2353
Bit Digital
BTBT
$945M
| $929 | ﹤0.01% |
460
+295
| +179% | +$596 |
|
2354
Cogent Biosciences
COGT
$1.79B
| $928 | ﹤0.01% |
155
+85
| +121% | +$509 |
|
2355
Primis Financial Corp
FRST
$269M
| $928 | ﹤0.01% |
95
+40
| +73% | +$391 |
|
|
CLDT
2356
Chatham Lodging
CLDT
$349M
| $927 | ﹤0.01% |
130
+5
| +4% | +$36 |
|
2357
Northfield Bancorp
NFBK
$487M
| $927 | ﹤0.01% |
85
+55
| +183% | +$600 |
|
2358
iShares Global Clean Energy ETF
ICLN
$1.59B
| $925 | ﹤0.01% |
81
| – | – |
|
2359
Amdocs
DOX
$9.39B
| $915 | ﹤0.01% |
10
+5
| +100% | +$458 |
|
2360
JPMorgan Ultra-Short Income ETF
JPST
$33.5B
| $911 | ﹤0.01% |
18
| – | – |
|
2361
CONMED
CNMD
$1.63B
| $906 | ﹤0.01% |
15
-55
| -79% | -$3.32K |
|
2362
Metals Acquisition
MTAL
$1.01B
| $906 | ﹤0.01% |
95
+40
| +73% | +$381 |
|
2363
Cimpress
CMPR
$1.44B
| $905 | ﹤0.01% |
20
+15
| +300% | +$679 |
|
2364
Cantaloupe
CTLP
$792M
| $905 | ﹤0.01% |
115
+15
| +15% | +$118 |
|
2365
Match Group
MTCH
$9.15B
| $905 | ﹤0.01% |
29
-45
| -61% | -$1.4K |
|
|
BFS
2366
Saul Centers
BFS
$779M
| $902 | ﹤0.01% |
25
-5
| -17% | -$180 |
|
2367
Cytek Biosciences
CTKB
$476M
| $902 | ﹤0.01% |
225
+80
| +55% | +$321 |
|
2368
Atkore
ATKR
$2.04B
| $900 | ﹤0.01% |
15
-40
| -73% | -$2.4K |
|
2369
Zevra Therapeutics
ZVRA
$448M
| $899 | ﹤0.01% |
120
+35
| +41% | +$262 |
|
2370
JFrog
FROG
$5.82B
| $896 | ﹤0.01% |
28
| – | – |
|
2371
Grindr
GRND
$3.07B
| $895 | ﹤0.01% |
50
| – | – |
|
2372
Arrowhead Research
ARWR
$4.11B
| $892 | ﹤0.01% |
70
-135
| -66% | -$1.72K |
|
2373
WideOpenWest
WOW
$440M
| $891 | ﹤0.01% |
180
+110
| +157% | +$545 |
|
2374
Enliven Therapeutics
ELVN
$1.14B
| $886 | ﹤0.01% |
45
+5
| +13% | +$98 |
|
2375
Denali Therapeutics
DNLI
$2.14B
| $884 | ﹤0.01% |
65
-35
| -35% | -$476 |
|